Since childhood, Rachael Petersen had lived with an unexplainable sense of grief that no drug or talk therapy could entirely ease. So in 2017 she volunteered for a small clinical trial at Johns Hopkins University that was testing psilocybin, the active ingredient in magic mushrooms, for chronic depression. “I was so depressed,” Petersen, 29, said… Read More »
MISSED PART 1 OF THIS EXECUTIVE INTERVIEW SERIES? READ NOW to learn about Dr. Wyatt Decker’s perspectives on the state and challenges of the health care industry, where it’s smart for leaders to focus, what change means for different stakeholders across health care and lessons learned from a physician executive. Imagine this scenario: there are… Read More »
Think you’re busy? Take a look at Pfizer’s commercial team for oncology, which is currently launching four new drugs, three new indications for older drugs, and a biosimilar. And that’s just in the U.S. It’s taken some serious internal organizing on Pfizer’s part, but so far managing the multiple rollouts has been “done very well,”… Read More »
(Photo by Marcus Ingram/Getty Images for UNICEF) Former NBA star Dikembe Mutombo is mourning the death of the 8-year-old African boy that he flew to the United States earlier this month for surgery to remove a tumor. The child, Matadi Sela Petit of Kinshasa, Congo, died after suffering a “rare and unpredictable genetic reaction to… Read More »